NCI-funded TMIST study compares 2-D and 3-D mammography for finding breast cancers
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of digital mammography for breast cancer screening, is now open for enrollment. The study was developed by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and the National Cancer Institute (NCI), part of the National Institutes of Health. ECOG-ACRIN is leading the trial.
TMIST researchers are enrolling healthy women ages 45 to 74 who are already planning to get routine mammograms. By taking part in TMIST, the 165,000 planned participants will provide critical information that will help researchers learn how to most effectively screen women for breast cancer and help women make informed decisions about the screening tests in the future.
How to join the TMIST mammography comparison study
For more information and a list of participating centers, see:
Read the Complete National Cancer Institute Press release: read more
Early detection is critical to beating cancer.
Walk-in-Lab provides a wide range of blood tests that can help you assess and improve your overall health and play a role in preventing cancer or its recurrence.
No doctor’s order is necessary and your confidential test results are available online.